Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of 5α-reductase Inhibition on the Regulation of Insulin Action and Metabolic Phenotype in Healthy Volunteers.

NCT01923090 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT01923090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of 5α-reductase Inhibition on the Regulation of Insulin Action and Metabolic Phenotype in Healthy Volunteers.
Lead sponsor
University of Birmingham
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2012
Completion date
October 31, 2013
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers